Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability
Sjoerd H. van der Burg(Leiden University Medical Center), C J Melief(Leiden University), Remco M.P. Brandt(Leiden University), Marjan J.W. Visseren(Leiden University), W. Martin Kast(University of Southern California)
Cited by 396
Related Papers
Therapeutic cancer vaccines
|Journal of Clinical Investigation|2015|1.1k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840